Buys
Open market- Shares
- Avg price
- Total value
Max Rosett - Chief Financial Officer at Immunome Inc.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- IMNM on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Max Rosett in Immunome Inc.
Sells
Open market- Shares
- -125,000
- Avg price
- $20.15
- Total value
- -$2,518,716
Net
Past year- Shares
- -125,000
- Share %
- -100%
- Total value
- -$2,518,716
Reported holdings for Max Rosett in Immunome Inc.
Form 4 holding
Chief Financial Officer
Immunome Inc.
- Security class
- Common Stock
- Shares / value
- 54,037
- Estimated value
- $985,094
- Report date
- 15 Jun 2026
- Price
- $18.23
- Ownership
- Direct
Form 4 holding
Chief Financial Officer
Immunome Inc.
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 207,000
- Estimated value
- Report date
- 29 Jul 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Financial Officer
Immunome Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 15 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Max Rosett in Immunome Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.